玉液汤联合阿卡波糖治疗糖耐量减低(IGT)患者临床观察

Yuye Tang Joint Acarbose Treatment of IGT in Patients with Clinical Observation

目的:观察玉液汤联合阿卡波糖治疗IGT患者的临床疗效。方法:将120例符合标准的IGT患者随机分为两组,每组60例,两组患者无显著差异,具有可比性。两组都给予饮食和运动干预,在此基础上,对照组给予阿卡波糖,治疗组给予玉液汤联合阿卡波糖进行治疗。治疗16周,观察治疗前后两组患者的2h OGTT、FPG、FINS、HbA1c,以及脱离IGT状态的达标率。结果:治疗组和对照组患者的2h OGTT、FPG、HbA1c和FINS都显著降低,而治疗组FINS的降低更显著;治疗组患者脱离IGT状态的达标率显著高于对照组。结论:玉液汤联合阿卡波糖治疗IGT患者的疗效优于单纯使用阿卡波糖治疗。

Objective：Observe the clinical efficacy of Yuye Tang joint acarbose treatment of IGT patients.Method：120 patients met the criteria of IGT patients were randomly divided into two groups,each group of 60 cases,patients were no significant differences were comparable.The two groups were given diet and exercise intervention on this basis,the control group were given acarbose treatment group received Yuye soup joint acarbose treatment.16 weeks of treatment,observation and treatment of two groups of patients before and after 2h of OGTT,FPG and FINS and HbA 1c,as well as from the IGT state compliance rate.Result：Treatment group and control group of patients with 2h of OGTT,FPG and HbA1c and FINS are significantly reduced,FINS of the treatment group reduced more significantly;treatment group compliance rate was significantly higher from the IGT state.Conclusion：Yuye Tang acarbose treatment of IGT patients more effective than simply the use of acarbose treatment.